XML 53 R21.htm IDEA: XBRL DOCUMENT
v3.23.1

Acquisition of Atrin Pharmaceuticals (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Acquisition of Atrin Pharmaceuticals |
Schedule of net assets acquired based on the estimated fair values | ​
​ | ​ | ​ | ​
Acquired IPR&D | ​ | $ | 76,020,184
Cash and cash equivalents | ​ | ​ | 2,489,745
Prepaid expenses and other assets | ​ | ​ | 34,579
Accounts payable and accrued liabilities | ​ | ​ | (2,336,462)
Total Acquisition Value | ​ | $ | 76,208,046
​

X
- References No definition available. + Details
Name: | us-gaap_AssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of asset acquisition. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 50 -Section 15 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492 + Details
Name: | us-gaap_AssetAcquisitionTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration